Karyopharm Therapeutics Inc (NASDAQ:KPTI)

26.15
Delayed Data
As of May 22
 -0.12 / -0.46%
Today’s Change
24.02
Today|||52-Week Range
49.01
-30.14%
Year-to-Date

Today’s Trading

Previous close26.27
Today’s open26.32
Day’s range25.81 - 26.68
Volume342,127
Average volume (3 months)357,166
Market cap$933.4M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+56.53%
Earnings growth (this year)-27.33%
Earnings growth (next 5 years)-13.68%
Revenue growth (last year)-40.83%
P/E ratioNM
Price/Sales5,089.12
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.37+1.19%
RPTPRaptor Pharmaceutica...-0.08-0.67%
ITCIIntra-Cellular Thera...+0.25+1.01%
EGRXEagle Pharmaceutical...+1.32+2.06%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$229.0K
Annual profit (last year)-$75.8M
Net profit margin-33,090.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers